Anzeige
Mehr »
Donnerstag, 06.08.2026 - Börsentäglich über 12.000 News
SalesCloser Technologies: Facebook, YouTube, Instagram, WhatsApp oder TikTok!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
229 Leser
Artikel bewerten:
(1)

AGS Health Named 2026 Top Clinical Denial and Appeal Management Services Vendor by Black Book Research

WASHINGTON, D.C. / ACCESS Newswire / August 6, 2026 / AGS Health, a leading provider of technology-first revenue cycle management (RCM) solutions serving healthcare providers across the U.S. through a comprehensive platform combining AI-driven solutions, data analytics, and specialized global delivery capabilities, has been named the top clinical denial and appeal management services vendor for 2026 by Black Book Research, the healthcare industry's independent source for crowdsourced IT and outsourcing performance insights. The ranking was published in Black Book's 2026 State of Health & Hospital Systems Revenue Cycle Management Technology & Services report, which evaluates client-ranked RCM software, services, and technology-enabled operations vendors nationwide.

The AGS Health approach to clinical denial and appeal management involves reviewing and classifying denial reasons, identifying denial root causes, and submitting appeals with appropriate supporting documentation to recover lost revenue. Under this physician-led model, AI enhances the process, subject to defined quality controls and human review for exceptions and complex clinical matters.

Black Book's rankings are based solely on client feedback, with scoring designed to reflect current-year performance indicators, including workflow fit, implementation reliability, user adoption, operational impact, auditability, support responsiveness, and measurable financial value. The 2026 report evaluates 420 RCM vendors across 18 qualitative KPIs in 49 ranked offering categories. It features an expanded methodology emphasizing payer-friction detection, preventable-denial logic, prior authorization requirement detection and evidence assembly, human-in-the-loop AI controls, model observability, and audit trail transparency.

"This Black Book ranking reflects the confidence our clients place in AGS Health's ability to address increasingly complex clinical denials, which have emerged as one of the fastest growing and most challenging problems in healthcare RCM," said Cheryl Cruver, President of U.S. Markets and Chief Commercial Officer, AGS Health. "Today's healthcare organizations, including 74% of Black Book survey respondents, are now prioritizing denial prevention over post-denial recovery. We support this transition by coupling clinical expertise with operational efficiency, and we're honored to be recognized for the measurable impact this model is delivering."

AGS Health intends to maintain its position as a technology leader in the RCM industry by continuing to invest in AI, ML, natural language processing, and automation capabilities as part of its broader clinical administrative services. In doing so, the company will enhance its ability to help healthcare organizations improve denial prevention, strengthen reimbursement performance, and reduce administrative burden while maintaining defined quality controls.

The complete list of top RCM vendors can be found here.

About AGS Health

AGS Health serves large health systems, physician groups, and hospitals across the U.S. The company's approach combines technology-enabled revenue cycle services, intelligent automation, and customer support across front-end, mid-cycle, and back-end revenue cycle workflows, including patient financial engagement. AGS Health employs a team of approximately 16,000 employees supporting customers across diverse care settings and specialties. For more information, visit www.agshealth.com

# # #

Media Contact

Liz Goar
liz@npccs.com

SOURCE: AGS Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ags-health-named-2026-top-clinical-denial-and-appeal-management-servi-1203440

© 2026 ACCESS Newswire
Achtung, Korrektur!
Die Börsen laufen heiß. Trotz geopolitischer Krisen und steigender Zinsen klettern viele Indizes weiter Richtung Allzeithoch. Doch unter der Oberfläche zeigen sich erste Risse: Der Abverkauf bei Halbleiter-, KI- und Space-Aktien macht deutlich, wie schnell sich die Stimmung drehen kann.

Besonders gefährlich ist die aktuelle Gemengelage aus schwacher Saisonalität, dünner Liquidität in den Sommermonaten und historisch hohen Bewertungen. Selbst vermeintlich sichere Blue Chips sind inzwischen teuer bewertet und damit anfällig für Korrekturen. Gleichzeitig liefern technische Indikatoren erste Warnsignale. So werden viele Rekordstände nicht mehr bestätigt.

Für Anleger steigen die Risiken spürbar. Wer jetzt nicht genauer hinschaut, läuft Gefahr, auf dem falschen Fuß erwischt zu werden.

In unserem aktuellen Spezialreport zeigen wir fünf Aktien, bei denen die Abwärtsrisiken besonders hoch sind – und wo sich Gewinnmitnahmen oder sogar Short-Strategien anbieten könnten.

Jetzt den kostenlosen Report sichern – bevor die Korrektur Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.